Musculoskeletal Care 3.0

One of the most meaningful shifts in musculoskeletal medicine over the past two decades has been the migration of procedures once reserved for the operating room into the office setting — made possible by the precision and real-time visualization that high-resolution diagnostic ultrasound provides. I had the opportunity to hear Dr. Adam Pourcho present at AOCPMR 2025, sharing more than twenty years of clinical and procedural experience in this space, and the outcomes data he presented reinforced what I have seen in my own practice: ultrasound-guided minimally invasive procedures are reducing pain, accelerating recovery, and allowing patients to avoid surgery for conditions that previously left them with few alternatives.

THE BASICS

Why Ultrasound Guidance Changes What Is Possible

The value of ultrasound in interventional musculoskeletal medicine is not simply that it allows you to see what you are doing — though that alone is significant. It is that it allows you to do things with precision that would otherwise require an incision, a tourniquet, a surgical suite, and weeks of recovery. Real-time imaging means the needle, the device, or the energy being delivered is visualized continuously in relation to the target tissue and the structures that must be protected. That precision translates directly into smaller access points, local anesthesia only, faster return to work and activity, lower infection risk, and fewer complications — not as theoretical advantages but as documented outcomes across a growing body of clinical literature. The procedures that have benefited most from this transition are among the most common musculoskeletal conditions I see in practice.

CLINICAL EVIDENCE

What the Data Shows Across Key Procedures

Carpal tunnel syndrome is the most common peripheral nerve entrapment in the body, with more than 450,000 surgical releases performed annually in the United States. Ultrasound-guided carpal tunnel release — performed in the office under local anesthesia without a tourniquet or sutures — has produced return-to-activity timelines of three to five days on average in published series, compared to weeks for traditional open or endoscopic surgical approaches. Pillar pain, a frequent and sometimes prolonged complication of conventional carpal tunnel surgery related to disruption of the transverse carpal ligament attachment, is minimal or avoided entirely with the ultrasound-guided technique. Trigger finger and de Quervain's tenosynovitis release follow a similar principle — a precise in-office procedure performed under real-time imaging to release the affected tendon sheath while protecting adjacent neurovascular structures, with most patients returning to normal activity within 48 hours and high satisfaction rates documented across populations including postpartum women and manual laborers for whom prolonged recovery is particularly consequential.

For chronic tendinopathies — conditions affecting the lateral elbow, Achilles tendon, patellar tendon, plantar fascia, rotator cuff, and proximal hamstring — ultrasound-guided tendon debridement using focused ultrasonic energy to precisely remove degenerated tissue has demonstrated greater than 90 percent improvement in function in published outcomes data, with a complication profile that compares favorably to open surgical debridement. The critical conceptual shift underlying this approach is a reconceptualization of what chronic tendon pain actually represents. The term tendinitis implies an inflammatory process, but the histological reality of most chronic tendon pain is tissue breakdown, collagen disorganization, and neovascularization — a degenerative rather than an inflammatory process. This distinction matters clinically because it explains why corticosteroid injections, while providing short-term symptom relief, frequently produce long-term tendon damage and elevated rupture risk when used repeatedly. The tendon is not inflamed — it is failing, and the appropriate response is regenerative rather than suppressive.

PATIENT SELECTION

Who Benefits From Ultrasound-Guided Minimally Invasive Treatment

The patients best suited to these procedures share a common clinical profile: a well-defined structural diagnosis confirmed on ultrasound or MRI, a history of incomplete or temporary response to conservative management including physical therapy and conventional injections, and a desire to avoid or delay surgery. For carpal tunnel syndrome this means confirmed median nerve compression with appropriate electrodiagnostic findings. For trigger finger and de Quervain's it means a defined tendon sheath pathology that has not resolved with splinting and corticosteroid injection. For chronic tendinopathy it means a degenerative tendon lesion on imaging that has failed a structured rehabilitation program and conservative injection management.

In addition to procedural debridement, orthobiologic therapies play an important role in the tendinopathy treatment algorithm. Platelet-rich plasma delivered under ultrasound guidance to the degenerative tendon zone provides concentrated growth factors that stimulate the repair cascade the tendon can no longer initiate independently. Alpha-2-macroglobulin and IRAP protein injections represent additional biologic options targeting the protease-driven degradation that characterizes tendon failure at the molecular level. Ultrasound-guided tendon scraping — a technique that mechanically disrupts the pathological neovascularity driving chronic tendon pain — complements these biologic approaches by addressing the structural abnormality directly. These therapies are most effective when delivered precisely to the pathological tissue, which is exactly what ultrasound guidance makes possible.

FOR REFERRING CLINICIANS

Patients with carpal tunnel syndrome, trigger finger, de Quervain's tenosynovitis, or chronic tendinopathy who have not achieved adequate relief with conservative management are appropriate referral candidates for ultrasound-guided minimally invasive evaluation and treatment. I offer comprehensive diagnostic musculoskeletal ultrasound, electrodiagnostic assessment for peripheral nerve entrapment, and the full range of ultrasound-guided interventional procedures described above — all performed in an office setting without the logistical burden or recovery timeline of surgical referral. For many of these patients, the right intervention at the right time eliminates the need for an operative consultation entirely. I welcome direct physician-to-physician consultation.

PERSPECTIVE

A Note on Precision as a Standard, Not a Differentiator

There was a time when image-guided musculoskeletal procedures were considered advanced or specialized — something performed only at academic centers or by a small number of fellowship-trained specialists. That time has passed, and the standard of care for delivering injections, performing soft tissue procedures, and treating peripheral nerve pathology has moved decisively toward ultrasound guidance as the expected approach rather than the exceptional one. What continues to differentiate outcomes is not simply whether ultrasound is used, but the depth of anatomical knowledge, procedural experience, and diagnostic accuracy that guides its application. A needle placed under ultrasound guidance by a physician who does not fully understand the three-dimensional anatomy of the target structure, or who has not accurately diagnosed the pain generator driving the patient's symptoms, produces no better outcome than a landmark-based injection. The technology is the enabler. The physician is still the variable that matters most. That is the standard I hold myself to in every procedure I perform, and it is the standard every patient deserves.

DISCLOSURE & REFERENCES

This article is for educational purposes and reflects clinical experience and interpretation of published literature. It is not a substitute for individualized medical evaluation. Key references: Pourcho AT et al. (AOCPMR 2025 presentation, ultrasound-guided minimally invasive procedures); Rojo-Manaute JM et al. 2014 (ultrasound-guided carpal tunnel release, J Ultrasound Med); Baumgarten KM et al. (trigger finger outcomes); Finnoff JT et al. 2017 (ultrasound-guided procedures in sports medicine, PM&R); Challoumas D et al. 2019 (PRP for tendinopathy systematic review, BMJ Open Sport Exerc Med); Cook JL & Purdam CR 2009 (tendon pathology continuum, BJSM).

ABOUT THE AUTHOR

Dr. Mahajer is a double board-certified physiatrist and sports medicine physician, fellowship-trained in Interventional Spine & Sports Medicine at the Icahn School of Medicine at Mount Sinai. He is an Assistant Professor of Neuroscience at FIU Herbert Wertheim College of Medicine. He is the Immediate Past President of the American Osteopathic College of Physical Medicine and Rehabilitation (AOCPMR), holds medical licenses in Florida, New York, and California, and has been recognized as a Top Physiatrist and Top Doctor in both Florida and New York.